DIATRIZOATE MEGLUMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Diatrizoate Meglumine, and what generic alternatives are available?
Diatrizoate Meglumine is a drug marketed by Bracco, Anda Repository, and Annora Pharma. and is included in three NDAs.
The generic ingredient in DIATRIZOATE MEGLUMINE is diatrizoate meglumine; diatrizoate sodium. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diatrizoate Meglumine
A generic version of DIATRIZOATE MEGLUMINE was approved as diatrizoate meglumine; diatrizoate sodium by ANDA REPOSITORY on June 27th, 2022.
Summary for DIATRIZOATE MEGLUMINE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 32 |
| Clinical Trials: | 1 |
| Patent Applications: | 890 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DIATRIZOATE MEGLUMINE at DailyMed |
Recent Clinical Trials for DIATRIZOATE MEGLUMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Lawson Health Research Institute | Phase 4 |
Pharmacology for DIATRIZOATE MEGLUMINE
| Drug Class | Radiographic Contrast Agent |
| Mechanism of Action | X-Ray Contrast Activity |
Medical Subject Heading (MeSH) Categories for DIATRIZOATE MEGLUMINE
US Patents and Regulatory Information for DIATRIZOATE MEGLUMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bracco | DIATRIZOATE MEGLUMINE | diatrizoate meglumine | INJECTABLE;INJECTION | 010040-017 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Anda Repository | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | diatrizoate meglumine; diatrizoate sodium | SOLUTION;ORAL, RECTAL | 214201-001 | Jun 27, 2022 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Annora Pharma | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | diatrizoate meglumine; diatrizoate sodium | SOLUTION;ORAL, RECTAL | 215049-001 | Nov 17, 2023 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
